Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study
(2025)
Journal Article
Patone, M., Snelling, A. J., Tibble, H., Coupland, C., Sheikh, A., & Hippisley-Cox, J. (2025). Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study. Communications Medicine, 5(1), Article 20. https://doi.org/10.1038/s43856-024-00720-7
Background
Sotrovimab is a neutralising monoclonal antibody (nMAB) currently available to treat extremely clinically vulnerable COVID-19 patients in England. Trials have shown it to have mild to moderate side effects, however, evidence regarding its...
Read More about Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study.